# Study of Vioxx and Radiation Therapy for Brainstem Glioma

> **NCT00038389** · PHASE1 · TERMINATED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 8 (actual)

## Conditions studied

- Glioma
- Brain Neoplasms

## Interventions

- **DRUG:** Vioxx

## Key facts

- **NCT ID:** NCT00038389
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2001-10
- **Primary completion:** 2004-10
- **Final completion:** 2005-01
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** Unavailability of study drug.
- **Last updated:** 2018-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00038389

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00038389, "Study of Vioxx and Radiation Therapy for Brainstem Glioma". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT00038389. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*